NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Pre- and post-menopausal women or men with advanced (loco regionally recurrent not amenable to curative therapy or metastatic)HER2-positive breast cancer who have progressed to trastuzumab based chemotherapy and AntiHER2-ADC
1 total trials
Filter these 1 trials by phase, country, sponsor and more.